Med. praxi. 2011;8(11):463-465 [Klin Farmakol Farm. 2010;24(4):181-183]

Influence of antibacterial treatment on the development of bacterial resistence

prof.MUDr.Milan Kolář, Ph.D.1, doc.MUDr.Karel Urbánek, Ph.D.2, MUDr.Vojtěch Hanulík1, Mgr.Vladimíra Vojtová2
1 Ústav mikrobiologie LF UP a FN Olomouc
2 Ústav farmakologie LF UP a FN Olomouc

The review deals with a question of bacterial resistance to antibiotics. Most important phenotypes of the bacterial resistance are described,

including the real examples of the important pathogens’ resistance development in the University Hospital in Olomouc, Czech Republic.

On the basis of these data, the principles of antibacterial treatment are stated.

Keywords: bacteria, resistance, antibiotics

Published: January 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kolář M, Urbánek K, Hanulík V, Vojtová V. Influence of antibacterial treatment on the development of bacterial resistence. Med. praxi. 2011;8(11):463-465.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111: 676-685. Go to original source... Go to PubMed...
    2. European Antimicrobial Resistance Surveillance System. http://www.ecdc.europa.eu/en/activities/surveillance/EARSNet/Pages/index.aspx.
    3. Kang CI, Sung HK, Park WB, et al. Clinical outcome of bacteremic spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Korean J Intern Med 2004; 19: 160-165. Go to original source... Go to PubMed...
    4. Pai H, Kang CI, Byeon JH, et al. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48: 3720-3728. Go to original source... Go to PubMed...
    5. Tumbarello M, Sanguinetti M, Montuori E, et al. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 2007; 51: 1987-1994. Go to original source... Go to PubMed...
    6. Fuller JD, Low DE. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis 2005; 41: 118-121. Go to original source... Go to PubMed...
    7. Micek ST, Lloyd AE, Ritchie DJ, et al. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 2005; 49: 1306-1311. Go to original source... Go to PubMed...
    8. Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150: 1545-1549. Go to original source... Go to PubMed...
    9. Kolář M, Látal T, Čermák P. Klinicko-mikrobiologické podklady racionální antibiotické léčby. Trios, 2002.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.